ask="3.750"
ask_size="100"
average_daily_volume="3892"
bid="2.740"
bid_size="100"
book_value="0.957"
change="-0.008"
change_from_200_day_moving_average="-0.247"
change_from_50_day_moving_average="-0.089"
change_from_52_week_high="-2.408"
change_From_52_week_low="0.332"
change_in_percent="-0.277%"
close="2.842"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.435"
ebitda="-13.34M"
eps_estimate_current_year="N/A"
eps_estimate_next_quarter="-0.070"
eps_estimate_next_year="-0.330"
ex_dividend_date="N/A"
float_shares="23083000"
high="2.876"
high_52_weeks="5.250"
last_trade_date="2/3/2017"
last_trade_price="2.842"
last_trade_size="200"
last_trade_time="12:12pm"
low="2.740"
low_52_weeks="2.510"
market_capitalization="101.56M"
moving_average_200_day="3.089"
moving_average_50_day="2.931"
name="Oasmia Pharmaceutical AB - Amer"
notes="N/A"
one_year_target_price="6.000"
open="2.848"
pe_ratio="N/A"
peg_ratio="0.000"
percent_change_from_200_day_moving_average="-8.009%"
percent_change_from_50_day_moving_average="-3.052%"
percent_change_from_52_week_high="-45.867%"
percent_change_from_52_week_low="+13.227%"
previous_close="2.850"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.978"
price_per_sales="55.769"
revenue="1.83M"
shares_outstanding="35736000"
short_ratio="2.940"
stock_exchange="NCM"
symbol="OASM"
volume="1300"
weeks_range_52="2.510 - 5.250"
